- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07463144
Evaluation of a Mobile Wellness Application and Wearable Fitness Tracker on Weight Management and Health Outcomes
Evaluation of App-only Users Compared With Wearable Band + App Users With Regard to Weight Management and Program Engagement on the BetterMe Platform
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obesity is a growing public health concern worldwide, contributing to chronic conditions such as type 2 diabetes, cardiovascular disease, and mental health challenges. Digital wellness interventions, including mobile apps and wearable devices, have the potential to support behavior change, physical activity, and weight management.
This study will examine whether adding a wearable fitness tracker to a mobile wellness application enhances health outcomes compared with app-only use or standard health information. The trial is decentralized, conducted remotely, and does not require in-person visits.
Participants will complete baseline assessments, be randomized into one of three study arms, and follow a structured program for 12 weeks. Self-reported surveys, weight measurements (with optional video verification), app usage data, and wearable-collected data (for the tracker group) will be used to evaluate outcomes.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30328
- Sterling Institutional Review Board - Remote/Virtual Participation Only
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 18+ years
- A baseline BMI ≥ 25
- Willing to use the BetterMe mobile wellness app and fitness tracker for the entirety of the study
- Ownership of a smartphone
- Currently inactive, as defined by acknowledging "several times a month" or "never" to the exercise frequency question in the screener
- Acknowledging "I believe I can do it" or "I'm uncertain, but willing to try" to the confidence to succeed question in the screener
- Willingness to use scales for body weighing and submit video recording
Exclusion Criteria:
- A baseline BMI < 25
- Pregnant or planning to become pregnant
- Breast-feeding or less than 6 months postpartum
- Currently diagnosed with insomnia, sleep apnea, or other clinical sleep disorder
- Diagnosed thyroid, liver, kidney, cardiovascular, moderate-severe depression or anxiety, bipolar disorder, schizophrenia, or cancer-related disease
- Recent significant weight loss (e.g., >5-10% in the last 6 months)
- Extreme life circumstances (e.g. family illness, recently lost job, going through a divorce)
- Cannot participate in a regular exercise routine for any reason during the course of the study (i.e. contraindications to exercise)
- Used the same mobile wellness app and/or fitness tracker in the last year
- Currently enrolled in an additional weight loss program (e.g. Noom, WW, health coaching) and/or working with a dietician
- Current, previous (in the last 6 months), or planned use of weight loss medications (e.g., Ozempic, Wegovy, etc.) (in the next 6 months)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: App + Fitness Tracker
Participants using both a mobile wellness app and a wearable fitness tracker.
|
Participants will use a commercially available mobile wellness app alongside a wearable fitness tracker.
The app provides personalized exercise programs, habit tracking, progress monitoring, and motivational support.
The wearable collects daily steps, heart rate, heart rate variability, and sleep metrics to enhance personalized feedback.
Participants are encouraged to engage with both tools daily over a 12-week period to support weight management, physical activity, and overall well-being.
|
|
Experimental: App Only
participants using only the mobile wellness app.
|
Participants will use the same mobile wellness app without the wearable fitness tracker.
The app delivers personalized exercise programs, habit tracking, progress monitoring, and motivational support.
Participants are encouraged to use the app daily over 12 weeks to support weight management, physical activity, and overall well-being.
|
|
Active Comparator: Control Group
Participants who follow their normal health/ exercise routines, and will receive access to the BetterMe wellness blog and weekly email content to provide general wellness information.
|
Participants will continue their usual health and exercise routines without access to the app or wearable tracker.
They will receive standard wellness information via email or blog posts over the 12-week study period.
This group serves as a comparison to evaluate the effects of the interventions on weight management, physical activity, and well-being.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Change
Time Frame: 3 months
|
Change in % body weight
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity
Time Frame: 3 months
|
Physical activity levels (self-reported via IPAQ (International Physical Activity Questionnaire) and wearable devices. Scale: IPAQ score ranges from 0 to 1000+ MET-minutes/week (where higher scores indicate higher activity levels). Wearable Tracking: Data from wearable devices will be summarized in minutes of activity per week. |
3 months
|
|
Mental Health: Total Anxiety Score
Time Frame: 3 months
|
Measured by the Generalized Anxiety Disorder 7-item scale (GAD-7).
The GAD-7 is a 7-item self-report questionnaire used to assess the severity of generalized anxiety disorder.
Each item is scored from 0 (not at all) to 3 (nearly every day).
The total score is calculated by summing the scores of all 7 items, resulting in a single value ranging from 0 to 21.
Higher scores indicate greater anxiety severity.
|
3 months
|
|
Mental Health: Depression Total Score
Time Frame: 3 months
|
Measured using the Patient Health Questionnaire-8 (PHQ-8).
The PHQ-8 is an 8-item self-report instrument used to measure the severity of depressive symptoms.
Each item is scored on a 4-point scale ranging from 0 (not at all) to 3 (nearly every day).
The total score is calculated by summing the scores of all 8 items, resulting in a single value ranging from 0 to 24.
Higher scores indicate greater severity of depressive symptoms.
|
3 months
|
|
Health-Related Quality of Life
Time Frame: 3 months
|
Short Form 12 (SF-12), Health-Related Quality of Life Scale Scale: Scores range from 0 to 100 (where higher scores indicate better health-related quality of life). |
3 months
|
|
App usage metrics: Time
Time Frame: 3 months
|
Metric: Time spent in app (minutes)
|
3 months
|
|
App usage metrics: Exercise Count
Time Frame: 3 months
|
Metric: Exercises started/completed (count)
|
3 months
|
|
App usage metrics: Frequency
Time Frame: 3 months
|
Metric: Frequency of logging (number of logins).
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nutrition Disorders
- Overnutrition
- Body Weight
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Overweight
- Obesity
- Amino Acids, Peptides, and Proteins
- Proteins
- Investigative Techniques
- Epidemiologic Research Design
- Epidemiologic Methods
- Research Design
- Methods
- Equipment and Supplies
- Macromolecular Substances
- Multiprotein Complexes
- Electrical Equipment and Supplies
- Diagnostic Equipment
- Wearable Electronic Devices
- Control Groups
- Amyloid
- Fitness Trackers
Other Study ID Numbers
- 12192
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity & Overweight
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
Clinical Trials on App + Fitness Tracker
-
Coeus Health, LLCCompletedWeight Loss | Health BehaviorUnited States
-
Mike O'Callaghan Military HospitalCompletedType II Diabetes MellitusUnited States
-
Eli Lilly and CompanyJoslin Diabetes CenterCompletedDiabetes Mellitus, Type 1United States
-
Virginia Commonwealth UniversityCystic Fibrosis FoundationWithdrawn
-
University Hospital TuebingenUnknownCancer | Fatigue | Physical ActivityGermany
-
University of LimerickCompletedCystic FibrosisIreland
-
Eli Lilly and CompanyWithdrawnType 1 Diabetes | Type 2 DiabetesUnited States
-
Colorado State UniversityCompleted
-
Columbia UniversityCompletedCongenital Abnormalities | Telerehabilitation | Orthotopic Heart Transplant | Cardiac Rehabilitation | Pediatric Cardiology | Telehealth | Pulmonary Arterial Hypertension (PAH)United States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedOvarian CancerUnited States